Edgewise Therapeutics officer proposes $39.2K sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Edgewise Therapeutics, Inc. (EWTX) officer Joanne Donovan gave notice of a proposed sale of 854 common shares, with an aggregate market value of $39,224.22 and an approximate sale date of November 16, 2026. Morgan Stanley Smith Barney LLC is listed as broker. The notice lists December 26, 2025 as the date of plan adoption or giving of instruction, if relying on Rule 10b5-1.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Employee Stock Purchase Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Rule 10b5-1 date is listed for Joanne Donovan’s proposed EWTX sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.